Compile Data Set for Download or QSAR
maximum 50k data
Found 19 Enz. Inhib. hit(s) with all data for entry = 1917
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Atea Pharmaceuticals

US Patent
LigandPNGBDBM347273(US10202412, Compound A)
Affinity DataEC50: >3.06E+5nMAssay Description:Test compounds were dissolved in DMSO and then prepared in eight half-log dilutions in MEM medium with 50 μg/mL gentamicin and 2% FBS (MA-104 ce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Atea Pharmaceuticals

US Patent
LigandPNGBDBM347283(US10202412, Compound W)
Affinity DataEC50:  600nMAssay Description:Test compounds were dissolved in DMSO and then prepared in eight half-log dilutions in MEM medium with 50 μg/mL gentamicin and 2% FBS (MA-104 ce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Atea Pharmaceuticals

US Patent
LigandPNGBDBM347275(US10202412, Compound K)
Affinity DataEC50: >2.25E+5nMAssay Description:Test compounds were dissolved in DMSO and then prepared in eight half-log dilutions in MEM medium with 50 μg/mL gentamicin and 2% FBS (MA-104 ce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Atea Pharmaceuticals

US Patent
LigandPNGBDBM347276(US10202412, Compound L)
Affinity DataEC50: >1.59E+5nMAssay Description:Test compounds were dissolved in DMSO and then prepared in eight half-log dilutions in MEM medium with 50 μg/mL gentamicin and 2% FBS (MA-104 ce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Atea Pharmaceuticals

US Patent
LigandPNGBDBM347277(US10202412, Compound O)
Affinity DataEC50: >2.93E+5nMAssay Description:Test compounds were dissolved in DMSO and then prepared in eight half-log dilutions in MEM medium with 50 μg/mL gentamicin and 2% FBS (MA-104 ce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Atea Pharmaceuticals

US Patent
LigandPNGBDBM347278(US10202412, Compound P)
Affinity DataEC50: >1.64E+5nMAssay Description:Test compounds were dissolved in DMSO and then prepared in eight half-log dilutions in MEM medium with 50 μg/mL gentamicin and 2% FBS (MA-104 ce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Atea Pharmaceuticals

US Patent
LigandPNGBDBM347279(US10202412, Compound S)
Affinity DataEC50: >3.06E+5nMAssay Description:Test compounds were dissolved in DMSO and then prepared in eight half-log dilutions in MEM medium with 50 μg/mL gentamicin and 2% FBS (MA-104 ce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Atea Pharmaceuticals

US Patent
LigandPNGBDBM347280(US10202412, Compound T)
Affinity DataEC50: >1.67E+5nMAssay Description:Test compounds were dissolved in DMSO and then prepared in eight half-log dilutions in MEM medium with 50 μg/mL gentamicin and 2% FBS (MA-104 ce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Atea Pharmaceuticals

US Patent
LigandPNGBDBM347281(US10202412, Compound U)
Affinity DataEC50: >2.94E+5nMAssay Description:Test compounds were dissolved in DMSO and then prepared in eight half-log dilutions in MEM medium with 50 μg/mL gentamicin and 2% FBS (MA-104 ce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Atea Pharmaceuticals

US Patent
LigandPNGBDBM347282(US10202412, Compound V)
Affinity DataEC50: >1.64E+5nMAssay Description:Test compounds were dissolved in DMSO and then prepared in eight half-log dilutions in MEM medium with 50 μg/mL gentamicin and 2% FBS (MA-104 ce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Atea Pharmaceuticals

US Patent
LigandPNGBDBM347283(US10202412, Compound W)
Affinity DataEC50:  9.60E+3nMAssay Description:Test compounds were dissolved in DMSO and then prepared in eight half-log dilutions in MEM medium with 50 μg/mL gentamicin and 2% FBS (MA-104 ce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Atea Pharmaceuticals

US Patent
LigandPNGBDBM347284(US10202412, Compound X)
Affinity DataEC50: >2.32E+5nMAssay Description:Test compounds were dissolved in DMSO and then prepared in eight half-log dilutions in MEM medium with 50 μg/mL gentamicin and 2% FBS (MA-104 ce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Atea Pharmaceuticals

US Patent
LigandPNGBDBM347285(US10202412, Compound Y)
Affinity DataEC50: >1.42E+5nMAssay Description:Test compounds were dissolved in DMSO and then prepared in eight half-log dilutions in MEM medium with 50 μg/mL gentamicin and 2% FBS (MA-104 ce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Atea Pharmaceuticals

US Patent
LigandPNGBDBM347286(US10202412, Compound Z)
Affinity DataEC50: >1.77E+5nMAssay Description:Test compounds were dissolved in DMSO and then prepared in eight half-log dilutions in MEM medium with 50 μg/mL gentamicin and 2% FBS (MA-104 ce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Atea Pharmaceuticals

US Patent
LigandPNGBDBM347287(US10202412, Compound C)
Affinity DataEC50: >1.00E+5nMAssay Description:Test compounds were dissolved in DMSO and then prepared in eight half-log dilutions in MEM medium with 50 μg/mL gentamicin and 2% FBS (MA-104 ce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Atea Pharmaceuticals

US Patent
LigandPNGBDBM347288(US10202412, Compound D)
Affinity DataEC50: >1.00E+5nMAssay Description:Test compounds were dissolved in DMSO and then prepared in eight half-log dilutions in MEM medium with 50 μg/mL gentamicin and 2% FBS (MA-104 ce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Atea Pharmaceuticals

US Patent
LigandPNGBDBM347277(US10202412, Compound O)
Affinity DataEC50: >1.00E+5nMAssay Description:Test compounds were dissolved in DMSO and then prepared in eight half-log dilutions in MEM medium with 50 μg/mL gentamicin and 2% FBS (MA-104 ce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Atea Pharmaceuticals

US Patent
LigandPNGBDBM347278(US10202412, Compound P)
Affinity DataEC50: >1.00E+5nMAssay Description:Test compounds were dissolved in DMSO and then prepared in eight half-log dilutions in MEM medium with 50 μg/mL gentamicin and 2% FBS (MA-104 ce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Atea Pharmaceuticals

US Patent
LigandPNGBDBM347274(US10202412, Compound B)
Affinity DataEC50: <1.68E+5nMAssay Description:Test compounds were dissolved in DMSO and then prepared in eight half-log dilutions in MEM medium with 50 μg/mL gentamicin and 2% FBS (MA-104 ce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent